On December 24丨Hunan Development (000722.SZ) announced that the company plans to sign an “Equity Transfer Agreement” with Hunan Pharmaceutical Development Private Equity Fund Management Co., Ltd. (“Pharmaceutical Private Equity Fund Company”) to transfer 82.50% of the shares held by the holding subsidiary Hunan Development Group Pension Industry Co., Ltd. (“Hunan Development Pension”) to the pharmaceutical private equity fund company for 617.1 million yuan. Mr. Nie Qinghua, another shareholder of Hunan Development Pension, has lost the priority purchase right of 82.50% of Hunan Development Pension's shares under the same conditions.
湖南发展(000722.SZ)：拟将湖南发展养老82.50%股权以617.10万元转让给医药私募基金公司
Hunan Development (000722.SZ): Plans to transfer 82.50% of Hunan Development Pension's shares to pharmaceutical private equity companies for 617.1 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.